英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

proveca ltd - glycopyrronium bromide - oral solution - 400microgram/1ml

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

thame laboratories ltd - lorazepam - oral solution - 1mg/1ml

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - risperidone - oral solution - 1mg/1ml

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - lamivudine, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: hydrochloric acid; methyl hydroxybenzoate; sodium citrate dihydrate; propyl hydroxybenzoate; sucrose; citric acid; propylene glycol; sodium hydroxide; purified water; flavour - zeffix (lamivudine) is indicated for the treatment of children (2 years and above), adolescent and adult patients with chronic hepatitis b and evidence of hepatitis b virus (hbv) replication. this indication is based on changes in serological and histological markers in clinical studies of up to 2 years duration in adult patients with compensated liver disease and serological data up to 18 months in children and adolescents. children and adolescent also require evidence of active hepatic inflammation. (see clinical trials). the safety and efficacy of zeffix (lamivudine) have not been established in patients with decompensated liver disease in placebo controlled studies. however, zeffix (lamivudine) has been shown to reduce hbv dna levels prior to and post liver transplantation.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

italfarmaco s.p.a. - cholecalciferol - oral solution - 25 000 iu international unit(s)/millilitre - vitamin d and analogues; colecalciferol - vitamin d3 and analogues, cholecalciferol - • prophylaxis of rickets and osteomalacia in children and adults • prophylaxis of rickets in preterm newborns • prophylaxis of vitamin d deficiency in children and adults with an identified risk • prophylaxis of vitamin d deficiency in children and adults with malabsorption • treatment of rickets and osteomalacia in children and adults

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - furosemide - oral solution - 8 milligram(s)/millilitre - sulfonamides, plain; furosemide - high-ceiling diuretic sulfonamide - furosemide is indicated in all conditions requiring prompt diuresis in patients who are unable to take solid dose forms. indications include cardiac, pulmonary, hepatic and renal oedema, peripheral oedema due to mechanical obstruction or venous insufficiency and hypertension.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - furosemide - oral solution - 10 milligram(s)/millilitre - sulfonamides, plain; furosemide - high-ceiling diuretic sulfonamide - furosemide is indicated in all conditions requiring prompt diuresis in patients who are unable to take solid dose forms. indications include cardiac, pulmonary, hepatic and renal oedema, peripheral oedema due to mechanical obstruction or venous insufficiency and hypertension.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

syri limited, t/a thame laboratories - furosemide - oral solution - 4 milligram(s)/millilitre - sulfonamides, plain; furosemide - high-ceiling diuretic sulfonamide - furosemide is indicated in all conditions requiring prompt diuresis in patients who are unable to take solid dose forms. indications include cardiac, pulmonary, hepatic and renal oedema, peripheral oedema due to mechanical obstruction or venous insufficiency and hypertension

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - methadone hydrochloride - oral solution - 1mg/1ml

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - methadone hydrochloride - oral solution - 1mg/1ml